Non-smallCellLungCancerby
LungHealth ..
. CHRISTOPHER G. AZZOLI, MD: The most common form of lungcancer is called non-smallcelllungcancer. About 15 percent of lungcancer is smallcelllungcancer. ANNOUNCER: Lungcancers don't tend to stay put. They often tend to spread
Persistent racial disparities in lungcancer treatmentby
Katherine B.
of treatment for non-smallcelllungcancer," the authors write. Only then will black lungcancer patients experience... in a large cohort of elderly black and white patients with non-smallcelllungcancer." Dale Hardy, Chih-Chin Liu, Rui
LungCancer May Be Deadlier for ...by
Dr. Rubens D.
was safe and improved survival of patients with advanced non-smallcelllungcancer.The study found that the use...LungCancer May Be Deadlier for Menov 2008-- Men are more likely to die from inoperable non-smallcelllung
Hormone therapy lifts lung cance ...by
Dr. Rubens D.
, caused an extra death from non-smallcelllungcancer for each 100 women during the study.Doctors once thought... of time.Chlebowski said previous research suggested that hormones play a role in non-smallcelllungcancer, the most common form
New Hope for Advanced LungCancerby
LungHealth ..
ANNOUNCER: When doctors diagnose nonsmallcelllungcancer, they assign it a stage, often on a scale from one... advanced-stage nonsmallcelllungcancer would be whether the cancer is operable or not. And, usually, the cutoff
Drug Combo Proves Powerful Again ...by
Dr. Rubens D.
successful in safely slowing advanced non-smallcelllungcancer in a recent clinical trial.In the study, a phase 3... with 3.7 months for those on bevacizumab alone.Non-smallcelllungcancer, often linked to past tobacco use
Radiation therapy and inoperable lungcancerby
Katherine B.survival for patients with inoperable non-smallcelllungcancer, according to a study in the March 17 issue of JAMA... patients with early stage non-smallcelllungcancer. The Phase 2 study included patients 18 years or older with biopsy
Two drugs don't boost lung cance...by
Dr. Rubens D.
Two drugs don't boost lungcancersurvival: Roche By Emma Thomasson and Ben Hirschler 07 oct 2008--Roche... for lungcancer patients did not show an increase in overall survival. Both drugs are targeted therapies -- modern